In this episode of tHEORetically Speaking, join Dr. Pamela Landsman-Blumberg, Amanda O’Hora, and Ajay Keshava from Magnolia Market Access, who answer questions from a recent webinar on how early stage planning taking into account commercial production, logistics, reimbursement, and health inequities can lead to successful approvals and market adoption.
For more information, to watch the webinar, or access other resources, click here.
03/14/24 • 5 min
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/theoretically-speaking-318980/theoretically-speaking-cell-and-gene-therapies-46644206"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to theoretically speaking: cell & gene therapies on goodpods" style="width: 225px" /> </a>
Copy